Uniper and AM Green sign long-term offtake agreement for up to 500,000 tons per year of renewable ammonia from India
Uniper CEO Michael Lewis: "One of the first large-scale supply corridors between…
Etienna Bio Secures Exclusive Worldwide License from UMass Chan Medical School for Novel Adipose-Derived Regenerative Platform
LEAWOOD, Kan., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Etienna Bio, Inc., a…
At CES 2026, MSI unveiled its all-new Prestige series for business and productivity, along with the latest gaming laptops from the Raider, Stealth, and Crosshair series, all featuring brand-new designs
~ Launches the Prestige series and unveils next-generation Raider, Stealth and Crosshair…
From Idea to Print: Creality SPARKX i7 Debuts at CES 2026 for Everyday Creators
LAS VEGAS, Jan. 8, 2026 /PRNewswire/ -- On the opening day of…
From Trading to Wealth Preservation: Bybit Private Wealth Management Highlights 2025 Performance and New Year Outlook
DUBAI, UAE, Jan. 7, 2026 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency…
77% of global enterprises shift AI strategies from efficiency to growth
Nearly half of business leaders expect more than 15% revenue uplift from…
KuCoin Releases Australia Market Report: Over Half of Australian Crypto Funding Comes from Bank Transfers
The findings highlight growing demand for regulated exchanges that support seamless fiat…
Premium Portraits Launches AI Platform for Professional Business Headshots from Selfies
Swiss startup combines two decades of portrait photography expertise with AI to…
Nava Announces US$ 50 Million Buyback Proceeds from Wholly Owned Subsidiary, Singapore
Nava to receive US$ 50 Million as buy back proceeds from its…
Crinetics Pharmaceuticals to Provide PALSONIFY Business Update and Announce Topline Results from Fourth Cohort of Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia
January 04, 2026 16:00 ET | Source: Crinetics Pharmaceuticals, Inc. SAN DIEGO,…
